Torsten Freltoft - AcouSort Chief Officer
| ACOU Stock | SEK 2.59 0.01 0.38% |
Insider
Torsten Freltoft is Chief Officer of AcouSort AB
| Age | 65 |
| Phone | 46 45 20 45 08 54 |
| Web | https://www.acousort.com |
AcouSort Management Efficiency
The company has return on total asset (ROA) of (0.5716) % which means that it has lost $0.5716 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.2491) %, meaning that it generated substantial loss on money invested by shareholders. AcouSort's management efficiency ratios could be used to measure how well AcouSort manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Mattis Ranthe | ExpreS2ion Biotech Holding | N/A | |
| John MD | Modus Therapeutics Holding | 52 | |
| Thomas Pasold | Ortivus AB ser | 63 | |
| Sumeet MD | Alligator Bioscience AB | N/A | |
| Lars Petersen | ExpreS2ion Biotech Holding | N/A | |
| Prof MBA | Sprint Bioscience AB | 64 | |
| Mette Thorn | ExpreS2ion Biotech Holding | N/A | |
| Paul Hargreaves | Spago Nanomedical AB | 54 | |
| Pirkko Tamsen | Oncozenge AB | 64 | |
| Hanna MSc | Spago Nanomedical AB | 43 | |
| Claes Lindblad | Modus Therapeutics Holding | 56 | |
| Reidar Gardeback | Ortivus AB ser | 60 | |
| Bent MSc | ExpreS2ion Biotech Holding | N/A | |
| Julie Silber | Alligator Bioscience AB | N/A | |
| Joanna Daffy | Ortivus AB ser | N/A | |
| Jonas Bergh | Ortivus AB ser | 52 | |
| Elias Obaid | Ortivus AB ser | 35 | |
| Christoffer Tell | Simris Alg AB | 36 | |
| Pr Grewe | Simris Alg AB | N/A | |
| Karl Karlsson | Newbury Pharmaceuticals AB | 49 | |
| Max Sogaard | ExpreS2ion Biotech Holding | N/A | |
Management Performance
| Return On Equity | -1.25 | |||
| Return On Asset | -0.57 |
AcouSort AB Leadership Team
Elected by the shareholders, the AcouSort's board of directors comprises two types of representatives: AcouSort inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AcouSort. The board's role is to monitor AcouSort's management team and ensure that shareholders' interests are well served. AcouSort's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AcouSort's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Torsten Freltoft, Chief Officer | ||
| Hans Lilja, Founder | ||
| Pr Laurell, Founder Director | ||
| Stefan Scheding, Founder Director | ||
| Gunnar Telhammar, Chief Officer | ||
| Pr MD, Founder |
AcouSort Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AcouSort a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.25 | |||
| Return On Asset | -0.57 | |||
| Profit Margin | (2.05) % | |||
| Operating Margin | (2.04) % | |||
| Current Valuation | 218.36 M | |||
| Shares Outstanding | 13.2 M | |||
| Shares Owned By Insiders | 47.78 % | |||
| Price To Book | 10.71 X | |||
| Price To Sales | 34.85 X | |||
| Revenue | 3.01 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for AcouSort Stock Analysis
When running AcouSort's price analysis, check to measure AcouSort's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AcouSort is operating at the current time. Most of AcouSort's value examination focuses on studying past and present price action to predict the probability of AcouSort's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AcouSort's price. Additionally, you may evaluate how the addition of AcouSort to your portfolios can decrease your overall portfolio volatility.